{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:29:01Z","timestamp":1774877341997,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001722","name":"Royal Netherlands Academy of Arts and Sciences (KNAW)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.janxdis.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:44:36Z","timestamp":1525437876000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo"],"prefix":"10.1016","volume":"57","author":[{"given":"K.","family":"Meyerbr\u00f6ker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2331-9140","authenticated-orcid":false,"given":"N.","family":"Morina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.G.","family":"Emmelkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.janxdis.2018.05.001_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0005-7967(89)90091-0","article-title":"Cardiac and neuroendocrine responses to exposure therapy in height phobics: Desynchrony within the \u2018physiological response system\u2019","volume":"27","author":"Abelson","year":"1989","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2004"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopsycho.2012.01.007","article-title":"The effects of noradrenergic blockade on extinction in humans","volume":"89","author":"Bos","year":"2012","journal-title":"Biological Psychology"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-7967(96)00068-X","article-title":"Psychometric properties of the depression anxiety stress scale (DASS) in clinical samples","volume":"35","author":"Brown","year":"1997","journal-title":"Behavior Research Therapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychires.2007.05.006","article-title":"Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder","volume":"42","author":"Brunet","year":"2008","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1101\/lm.71504","article-title":"Adrenergic transmission facilitates extinction of conditional fear in mice","volume":"11","author":"Cain","year":"2004","journal-title":"Learning Memory"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1176\/ajp.144.8.1030","article-title":"Neurobiological mechanisms of panic anxiety: Biochemical and behavioral correlates of yohimbine-induced panic attacks","volume":"144","author":"Charney","year":"1987","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0005-7894(77)80116-0","article-title":"Comparison of self-report and overt-behavioral procedures for assessing acrophobia","volume":"8","author":"Cohen","year":"1977","journal-title":"Behaviour Therapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0045","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychological Bulletin"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0055","first-page":"433","article-title":"Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Ernst","year":"1998","journal-title":"Journal of Urulogy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0060","series-title":"Structured clinical interview for DSM-IV axis I disorders","author":"First","year":"1996"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0065","series-title":"Structured clinical interview for DSM-IV axis I disorders dutch translation by van lisse","author":"Groenestijn","year":"1999"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/RNN-139002","article-title":"Cognitive enhancers for the treatment of anxiety disorders","volume":"32","author":"Hofmann","year":"2014","journal-title":"Restorative Neurology and Neuroscience"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3934\/Neuroscience.2015.3.123","article-title":"Neuroenhancement of exposure therapy in anxiety disorders","volume":"2","author":"Hofmann","year":"2015","journal-title":"AIMS Neuroscience"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tips.2009.10.003","article-title":"Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders \u2013 the case of yohimbine","volume":"31","author":"Holmes","year":"2009","journal-title":"Trends in Pharmacological Science"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: A statistical approach to denning meaningful change in psychotherapy research","volume":"59","author":"Jacobson","year":"1991","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/10503300802448899","article-title":"Understanding how and why psychotherapy leads to change","volume":"19","author":"Kazdin","year":"2008","journal-title":"Psychotherapy Research"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cpp.693","article-title":"Inter-rater reliability of the structured clinical interview for DSM-IV axis I disorders (SCID I) and axis II disorders (SCID II)","volume":"18","author":"Lobbestael","year":"2011","journal-title":"Clinical Psychology and Psychotherapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","article-title":"The structure of negative emotional states: Comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories","volume":"33","author":"Lovibond","year":"1995","journal-title":"Behaviour Research and Therapy: An International Multi-disciplinary Journal"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1586\/14737175.2014.934677","article-title":"Enhancing exposure therapy for anxiety disorders, obsessive compulsive disorder, and posttraumatic stress disorder","volume":"14","author":"McGuire","year":"2014","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0110","first-page":"1","article-title":"Virtual reality exposure therapy in anxiety disorders: A systematic review of process- and outcome studies","volume":"0","author":"Meyerbr\u00f6ker","year":"2010","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0115","first-page":"1310","article-title":"Virtual reality exposure","volume":"Vol. II","author":"Meyerbr\u00f6ker","year":"2014"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000329454","article-title":"Does Yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial","volume":"81","author":"Meyerbroeker","year":"2012","journal-title":"Psychotherapy & Psychosomatics"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brat.2015.08.010","article-title":"Can virtual reality exposure therapy gains be generalized to real life? A meta-analysis of studies applying behavioral assessments","volume":"74","author":"Morina","year":"2015","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10862-007-9061-1","article-title":"Combining exposure and pharmacotherapy in the treatment of social anxiety disorder: A preliminary study of state dependent learning","volume":"30","author":"Morissette","year":"2008","journal-title":"Journal of Psychopathological Behavior Assessment"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1037\/0735-7044.121.3.501","article-title":"The effect of yohimbine on the extinction of conditioned fear: A role for context","volume":"121","author":"Morris","year":"2007","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0140","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1017\/S0033291799008703","article-title":"Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man","volume":"29","author":"O\u2019Carroll","year":"1999","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/da.20910","article-title":"Virtual reality exposure therapy in anxiety disorders: A quantitative meta-analysis","volume":"29","author":"Opris","year":"2012","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.1995.03950210068012","article-title":"Effects of Alzheimer\u2019s disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine","volume":"52","author":"Peskind","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.janxdis.2007.04.006","article-title":"Virtual reality exposure therapy for anxiety disorders: A meta-analysis","volume":"22","author":"Powers","year":"2008","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1037\/0022-006X.72.3.448","article-title":"Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: A placebo- controlled trial","volume":"72","author":"Powers","year":"2004","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0165","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1037\/0022-006X.76.3.478","article-title":"The effect of attributional processes concerning medication taking on return of fear","volume":"76","author":"Powers","year":"2008","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0170","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.janxdis.2009.01.001","article-title":"Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: A randomized placebo controlled trial of yohimbine augmentation","volume":"23","author":"Powers","year":"2009","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0005-7967(95)00083-6","article-title":"Cognitive behaviour links in the persistence of panic","volume":"34","author":"Salkovskis","year":"1996","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pharmthera.2014.12.004","article-title":"Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders","volume":"149","author":"Singewald","year":"2015","journal-title":"Pharmacological Therapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.janxdis.2012.07.006","article-title":"Aviophobia assessment: Validating the Flight Anxiety Situations Questionnaire as a clinical identification measure","volume":"26","author":"Skolnick","year":"2012","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0190","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biopsych.2013.10.008","article-title":"Yohimbine enhancement of exposure therapy for social anxiety disorder: A randomized controlled trial","volume":"75","author":"Smits","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.159.8.1420","article-title":"Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans","volume":"159","author":"Southwick","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0269881115612236","article-title":"Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis","volume":"30","author":"Steenen","year":"2016","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0205","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.janxdis.2011.05.001","article-title":"Cognitive processing and acrophobia: Validating the heights interpretation questionnaire","volume":"25","author":"Steinman","year":"2011","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0210","first-page":"1","article-title":"Augmenting treatment efficiency in exposure therapy for PTSD: A randomized double-blind placebo-controlled trial of yohimbine HCl","author":"Tuerk","year":"2018","journal-title":"Cognitive Behavior Therapy"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0215","series-title":"Multidisciplinaire richtlijn Angststoornissen (Derde revisie). Richtlijn voor de diagnostiek, behandeling en begeleiding van volwassen pati\u00ebnten met een angststoornis","author":"van Balkom","year":"2013"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1037\/1040-3590.11.2.146","article-title":"Construction and Psychometric Characteristics of two self-report questionnaires fort he assessment of fear of flying","volume":"11","author":"van Gerwen","year":"1999","journal-title":"Psychological Assessment"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.psyneuen.2005.05.012","article-title":"Salivary alpha amylase as maerker for adrenergic activity during stress: Effect of betablockade","volume":"31","author":"van Stegeren","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0230","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/0269881108092122","article-title":"Pharmacological enhancers of psychotherapeutical processes: The placebo problem","volume":"23","author":"Vervliet","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.janxdis.2018.05.001_bib0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.ijir.3900271","article-title":"Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction","volume":"9","author":"Vogt","year":"1997","journal-title":"International Journal of Impotency Research"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618517303626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618517303626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:07:41Z","timestamp":1760137661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887618517303626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":47,"alternative-id":["S0887618517303626"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2018.05.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733381797.793572157","asserted-by":"object"}]},"ISSN":["0887-6185"],"issn-type":[{"value":"0887-6185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}